Viewing Study NCT05067894


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-03-11 @ 9:09 PM
Study NCT ID: NCT05067894
Status: COMPLETED
Last Update Posted: 2022-08-09
First Post: 2021-10-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine
Sponsor: PT Bio Farma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module